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CHAPTER 1 
 
BACKGROUND 
 
Introduction 
Isolated from Pseudopterogorgia kallos by Rodriguez, bielschowskysin is a 
unique furanocembranoid natural product.1 In addition to its structural novelty and 
complexity, bielschowskysin exhibits antiplasmoidial activity against Plasmodium 
falciparum (IC50 = 10 µg/ mL) as well as in vitro cytotoxicity against EKVX nonsmall 
cell lung cancer (GI50 < 0.01 µM) and CAKI-1 renal cancer (GI50 < 0.51 µM). Its 
structural and biological profile renders the natural product an interesting target for total 
synthesis.  
 
Biosynthesis 
Bielschowskysin belongs to a unique class of diterpene natural products 
assembled by gorgonian corals.  These marine species are responsible for the production 
of most known furanocembranoids, pseudopteranes and gersolanes. Differing most 
markedly in carbocyclic ring size, these natural products are highly oxygenated – often 
featuring furan and butenolide moieties – and biosynthetically related.2 
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Figure 1: Furanocembranoid skeletons 
The proposed biosynthesis of the furanocembranoid ring system begins with 
geranylgeranyl diphosphate 1. Cyclization leads to generation of the cembrane skeleton, 
which upon deprotonation, forms neocembrane 3. Subsequent oxidation promotes 
formation of rubifolide 4, a supposed precursor for more complex furanocembranoids.2 
 
 
Scheme 1: Conversion of geranylgeranyl (1) diphosphate to rubifolide (4). 
 
Trauner has postulated that biosynthesis of bielschowskysin occurs through 
rubifolide 4. Advancement to intermediate 5 is accomplished through various oxidative 
processes. Further oxidation and hydration generates compound 6 which undergoes [2+2] 
photocycloaddition to yield the natural product.2 
  
 
Scheme 2: Proposed biosynthesis of bielschowskysin (7). 
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Alternate Routes 
 Due to its structural complexity, bielschowskysin has proven an interesting yet 
elusive target. Several groups, in addition to ours, have undertaken a total synthesis 
program. A noteworthy point of divergence among these routes is the manner in which 
the core cyclobutane functionality is installed.  
Similar to our route, Lear proposes a transannular [2+2]-photocycloaddition 
between an allene and a butenolide.3 In order to investigate the feasibility of this 
transformation, the group implemented a model system.  
Malic acid was reduced to triol 9 and converted to acetonide 10. Swern oxidation 
of the primary alcohol, addition of methyl magnesium bromide, and subsequent oxidation 
afforded methyl ketone 11. Ethynyl magnesium bromide addition resulted in tertiary 
alcohol 12, which underwent transketalization to the benzylidene acetal. Oxidation of the 
primary alcohol to the aldehyde followed by Wittig homologation yielded the 
predominately cis α,β-unsaturated ester 15. Upon treatment with sulfuric acid, the diol 
was liberated and spontaneously formed butenolide 16. Reaction of silyl ether 17 with 
paraformaldehyde gave photocycloaddition precursor 18. Upon irradiation in a solution 
of hexanes and dichloromethane, the allene butenolide was converted to cyclobutane 19. 
As of yet, there have been no reports of this methodology being employed in a 
transannular setting.  
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Scheme 3: Lear’s Route. 
 
Nicolaou and coworkers also favored a photochemical approach. They are able to 
access the [9.3.0.0] tetradecane ring system (27, Scheme 4) of bielschowskysin in five 
steps starting with furan 20. 4 Noyori reduction to the alcohol followed by CAN mediated 
coupling with β-ketoester 30 yields compound 21 as a mixture of C3 epimers, 22 and 23. 
Grubbs ring closing metathesis of 22 produced macrocycle 24, with the newly formed 
olefin in a predominately trans orientation. Attempted photocycloaddition with this 
substrate was unproductive. In an effort to render the olefin of the enol ether more 
reactive, ketone 25 was reduced to the allylic alcohol 26. Irradiation of 26 resulted in 27 
as a single diastereomer. 
 
 
Me
O
O
O
ethynyl magnesium
bromide
Et2O, - 78 °C 
72%
O
O
HO Me
CH2Cl2, 75%
TsOH, PhCH(OMe)2 O O
HO
Ph
Me
 (COCl)2, 
DMSO,
NEt3, CH2Cl2, 
- 78 °C
11 12
13
O O
O
Ph
Me
NEt3, MeOH, 0 !C 
60%
BrPCH2CO2Me O O
Ph
Me
CO2CH3
MeOH, 70%
H2SO4
O OH
HO
Me
CH2Cl2, 0 !C 
62%
TMSOTf/ 2,6-lutidine
O OH
TMSO
Me • CH2
H
O OH
TMSO
Me
dioxane, reflux, 68%
(CH2O)n,  i-Pr2NH, 
CuBr
hexanes; CH2Cl2,
 70%
h"#,
O O
HH
TMSO Me H
H
14 15 16
17 1918
O
O
O
OH
O
MeO2C
O
OHOMe
O
MeO2C
O
OHOMe
20 21 22 23
28, HCOONa
nBu4Cl
CH2Cl2/ H2O 
84%, 92% ee
29, CAN
MeOH, 0 °C
58%, 1:1 d.r.
5	  
 
Scheme 4: Nicolaou’s Route. 
 
Mulzer opted for a non-photochemical approach and began his synthesis with 
known bicyclic alcohol 31.5 Silyl ether 32 was converted to enone 33 via 
photooxygenation. Conjugate addition of a methyl cuprate followed by silyl ether 
formation and Saegusa oxidation yielded 35. Luche reduction and MOM-protection 
afforded compound 36, which underwent Mukaiyama-Isayama reaction to the tertiary 
alcohol. Silyl protection, selective deprotection yielded alcohol 38. Oxidation and 
alkylation at the α-position with formalin generated the quaternary carbon of the 
molecule. TES protection of the primary alcohols and treatment with Petasis’ reagent 
gave methylene 40. Exposure to Jones reagent resulted in tandem liberation of the 
primary alcohols and oxidation to the dicarboxylic acid. MOM deprotection was 
accompanied by lactone formation. Selective reduction of the remaining carboxylic acid 
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and subsequent oxidation to the aldehyde produced 43, establishing the eastern portion of 
bielschowskysin.  
 
 
Scheme 5: Mulzer’s Route. 
 
Stoltz and coworkers propose a tandem cyclopropane fragmentation/ Michael 
addition of intermediate 54 to arrive at 56. To this end, furan 43 was converted to the 
boronic acid and coupled with iodide 50.6 The group later found that the electron 
deficient olefin of the enone precluded cyclopropane formation. Thus, ketone 45 was 
selectively reduced to afford allylic alcohol 46. This substrate is amenable to an oxidative 
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kinetic resolution protocol developed in Stoltz’s lab. Notably, either enantiomer could be 
accessed from this method. 
 
 
Scheme 6: Stoltz’s synthesis of enantiomeric alcohols (47) and (48). 
 
Furan 46 was then acylated and coupled with a novel diazoacetoacetic acid reagent. 
Cyclopropanation with Cu(TBSal)2 afforded 53. They envisioned acetate removal, 
followed by oxidation with Dess Martin periodinane would arrive at key intermediate 54, 
which would undergo furan-assisted cyclopropane cleavage and subsequent Michael 
addition yielding the substituted cyclobutane. 
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Scheme 7: Stoltz’s approach to cyclobutane (56). 
 
However, when intermediate 53 was subjected to acetate removal, a drastically different 
compound, lactone 61, was obtained. Stoltz postulated that upon acetate cleavage of 53, 
intramolecular trans-lactonization affords 58. Oxidation of the free alcohol at C5, results 
in 59. Lewis acid promoted cleavage followed by addition of methanol yields 
intermediate 60. Conversion of the cyclic ketone to the hemiacetal via addition of 
methanol initiates a second trans –esterification to arrive at 61.   
1. Ac2O, DMAP
CH2Cl2
2. TBAF, THF, 0 °C
O
TBSO
CO2Me
HO
85%
O
HO
CO2Me
AcO
57, DCC, DMAP
CH2Cl2, 62%
O
O
CO2Me
AcO
O
N2
O
2 mol% Cu(TBSal)2
PhMe, 110 °C
or
10 mol% Cu(TBSal)2
µwave, DCE, !
50-55%
O
OAc
O
O CO2Me
O
1. K2CO3, MeOH
0 °C
2. DMP, CH2Cl2
46 51
52 53
HO
N2
O O
O
O
O CO2Me
O
O
La(OTf)3
MeOH, -55 °C O
O
O CO2Me
O
O
La
La
O
O
O
O
CO2Me
OMe
O H
H
57
54 55 56
9	  
 
Scheme 8: Stoltz’s route to unexpected compound (61). 
 
Theodorakis proposes a novel biomimetic synthesis of bielschowskysin via 
cembrenolide 62.7 He postulates that hydration, oxidation, and subsequent Michael 
addition of this cembrenolide should lead to an intermediate that can undergo either aldol 
closure to arrive at bielschowskysin or ketalization to arrive at verrillin.  
 
Scheme 9: Theoretical approach to verrillin and bielschowskysin. 
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 The C7-C12 fragment of the cembrenolide was synthesized from butynol 66. 
Conversion to ester 67 was accomplished in three steps. Copper mediated reduction of 
the alkyne followed by acid-induced cyclization afforded lactone 69. Treatment with 
LHMDS and PhSeBr effected selenation at the alpha position.  
 
 
Scheme 10: Theodorakis’ synthesis of the C7–C12 fragment. 
 
 Methyl zirconation and iodination of propargyl alcohol followed by silylation 
yielded vinyl iodide 72. Lithium halogen exchange and addition of oxirane resulted in 
homoallylic alcohol 73 which was further oxidized to the aldehyde completing the C1 – 
C13 fragment of the cembrenolide intermediate.  
 
 
Scheme 11: Theodorakis’ synthesis of the C1–C13. 
 
 Coupling of the two fragments and oxidation/ elimination of the selenide moiety 
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by selective deprotection gave primary alcohol 76. Coupling of fufural 80 and iodide 77 
was accomplished via a modified Stille. Appel reaction of the allylic alcohol resulted in 
formation of the bromide, which underwent NHK cyclization to macrocycle 79. 
However, attempted oxidation of the furan moiety with CAN led to a complex mixture of 
products rather than enol ether 63. 
 
 
 
Scheme 12: Theodorakis’ completion of route to common intermediate (79) 
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CHAPTER II 
 
CURRENT PROGRESS 
 
Sulikowski Route 
Initially, efforts toward the molecule centered on construction of the tetracyclic 
core. With this strategy in mind, bis-butenolide 82 was envisioned as a precursor to 
cyclobutane 81 via a [2+2] photocycloaddition. The required bis-butenolide could 
ultimately be derived from (-)-malic acid.   
 
 
Scheme 13: Retrosynthetic analysis of bielschowskysin (7). 
 
 In a 2006 manuscript, Doroh and Sulikowski disclosed the synthesis of 
intermediate 82 and its subsequent photocyclization to cyclobutane 81.8 Irradiation of an 
acetone solution of bis-butenolide 9 resulted in a 5:1 mixture of [2+2] photoadducts with 
the major product having the desired stereochemistry. Stereochemical assignments were 
confirmed by NOE and single-crystal x-ray analysis.   
 With an established protocol for the [2+2] photocycloddition, the group’s focus 
shifted to synthesis of an α–substituted butenolide which would provide a handle for 
elaboration of the eastern portion of the molecule. After several failed attempts to install 
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the substituted butenolide directly, the group resorted to Grieco’s method of selenation-
oxidation, accessing this moiety through lactone 85.9  
In a revised synthetic analysis, it was envisioned that formation of the macrocycle 
would arise from an intramolecular vinylogous aldol reaction of 83. Aldehyde 84 would 
enable installation of the required butenolide for this key reaction. The 
photocycloaddition precursor could be accessed from lactone 85, which could be derived 
from epoxide 86. As before (-)-malic acid would serve as the starting point of the 
synthesis.  
 
 
Scheme 14: Revised synthetic analysis of bielschowskysin (7). 
 
 Dr. Steve Townsend developed the route to advanced intermediate 84.  At the 
outset of the synthesis,  (-)-malic acid was converted to methyl ester 87 in three steps via 
a protocol reported by Saito.8, 10 Formation of the Weinreb amide and subsequent reaction 
with methyl Grignard generated ketone 11.11 Chelation-controlled addition of ethynyl 
magnesium bromide resulted in a 6:1 mixture of tertiary alcohols 12 and 88, with the 
major product having the desired 1,3 anti-oxygenated relationship observed in 
bielschowskysin.12, 13 Subsequent benzyl protection of the free alcohol gave benzyl ether 
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89. Exposure to acid liberated the diol, which upon addition to a slurry of sodium hydride 
and tosyl chloride resulted in concomitant formation of epoxide 8614, 15 The action of 
ynamine 91 on the epoxide followed by desilylation gave lactone 90 in 88% yield.16  
 
 
Scheme 15: Synthesis of lactone (90). 
 
 With formation of the lactone complete, the synthesis was directed toward 
extension of the carbon chain for construction of the alkylidene butenolide.  Sonogashira 
coupling of alkyne 90 and vinyl iodide 97 resulted in enyne 92.17, 18 Generation of the 
lithium enolate of 92 followed by addition of diphenyl diselenide resulted in 93. In the 
same manner, conversion to the disubstitued lactone was achieved upon aldol reaction 
with D-glyceraldehyde acetonide (98), producing the aldol adduct as a single 
diastereomer. Acylation was followed by TBAF deprotection and allylic oxidation to the 
aldehyde. Pinnick oxidation simultaneously resulted in conversion of the aldehyde to the 
carboxylic acid and oxidative elimination of the phenyl selenoxide to give the butenolide.  
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Completion of photocycloadditon precursor 96 was realized upon silver catalyzed 
cycloisomerization of acid 95.19, 20 
 
 
Scheme 16: Synthesis of bis-butenolide (96). 
 
 Using the previously established protocol for the [2+2] photocycloaddition, 
irradiation of bis-butenolide 96 in acetone afforded cyclobutane 99 as a single isomer.8 
Subsequent TFA removal of the acetonide and lead tetraacetate cleavage of the resultant 
diol provided aldehyde 84.  With the aldehyde in place, our focus shifted to 
functionalization of the eastern portion of the molecule and pursuit of an end-game 
strategy for bielschowskysin.   
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Scheme 17: Synthesis of advanced intermediate (84). 
 
Model System 
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Scheme 18: Synthesis of aldehyde (104). 
 
Wittig olefination with triphenyl phosphorane 105 afforded homologated 
aldehyde 106.  Sodium borohydride reduction resulted in allylic alcohol 107, an 
important intermediate allowing for synthetic divergence within the model system. 
Transformation of 107 to bromoacetal 108 was accomplished with NBS and neat ethyl 
vinyl ether. Employing a protocol established by Stork, radical cyclization of the 
bromoacetal was observed upon reflux with Bu3SnH and AIBN in benzene for five 
hours.23 Jones’ oxidation of the lactol yielded lactone 110. Subsequent enolization and 
reaction with Mander’s reagent provided the substituted lactone. Presumably, selenation 
followed by oxidation elimination would provide butenolide 112. Satisfied with the 
preliminary findings of the model system, we shifted our efforts toward scale-up of 
material and application of the newly explored chemistry to the front end.  
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Scheme 19: Synthesis of butenolide (112). 
 
Aldehyde 84 was converted to α,β-unsaturated aldehyde 113 without incident. 
However, attempted reduction to the allylic alcohol resulted in decomposition.  
 
 
Scheme 20: Application of model system chemistry to front end. 
 
Future Plans 
 Once intermediate 84 is advanced to butenolide 83, we will turn our attention to 
the completion of the molecule. We propose deprotonation at C2 will lead to a 
vinylogous aldol reaction resulting in formation of macrocycle 115. DIBAL reduction 
and subsequent hydrogenation is expected to provide lactol 116. Tosylation of the free 
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the exocyclic olefin and trans ring juncture simultaneously via an intermediate diazene.24 
Finally benzoate removal will result in bielschowskysin, 7.   
 
 
 
Scheme 21: Bielschowskysin end-game strategy. 
 
In an alternate strategy, we envision advancing bis-butenolide 96 to tris-
butenolide 119 via the model system chemistry and then attempting the 
photocycloaddition. 
 
  
Scheme 22: Proposed conversion to tris-butenolide 119.  
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Experimental Methods 
 
 
General. All non-aqueous reactions were performed under an argon atmosphere in oven-
dried glassware. Reagents were purchased at the highest commercial quality and used 
without further purification, unless otherwise stated. Diethyl ether (Et2O), acetonitrile 
(CH3CN), dichloromethane (CH2Cl2), and dimethylformamide (DMF) were obtained by 
passing commercially available formulations through activated alumina columns 
(MBraun MB-SPS solvent system). Tetrahydrofuran (THF) was obtained by distillation 
from benzophenone-sodium. Triethylamine (Et3N) and diisopropylamine were distilled 
from calcium hydride and stored over potassium hydroxide. Reactions were monitored by 
thin-layer chromatography (TLC) using E. Merck precoated silica gel 60 F254 plates. 
Visualization was accomplished with UV light and aqueous stain followed by charring on 
a hot plate. Flash chromatography was conducted using the indicated solvents and silica 
gel (230-400 mesh). Yields refer to chromatographically and spectroscopically 
homogenous materials. 1H and 13C NMR spectra were recorded on a Bruker 400 MHz 
spectrometer and are reported relative to deuterated solvent signals (7.26 and 77.2).   
 
Preparative Procedures 
 
To a solution of alcohol 101 (1.0 eq, 9.5 g, 74.1 mmol) in CH2Cl2 (120 
mL) at ambient temperature was added pyridine (100 mL), acetic 
anhydride (60 mL), and DMAP (1 crystal). The reaction was stirred 1 h, washed with 1 N 
HCl (3 x 50 mL), brine (1 x50 mL), dried (MgSO4), filtered, and concentrated in vacuo. 
OAc
102
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The crude residue was purified by distillation (72-74 °C) to provide acetate 102 (12.0 g, 
70.0 mmol, 95%) as colorless oil. Spectral data was consistent with reported values.25 
 
To a solution of acetate 102 (1.0 eq, 3.0 g, 17.6 mmol) in THF (90 mL) 
at ambient temperature was added OsO4 (1 crystal) and sodium 
periodate (1.5 eq, 5.7 g, 26.5 mmol) as a slurry in water (25 mL). The reaction was stirred 
4 h, diluted with Et2O (100 mL) and washed with saturated sodium bicarbonate (3 x 50 
mL), brine (1 x 50 mL), dried (MgSO4), filtered, and concentrated in vacuo. The crude 
residue was purified by column chromatography (7:1 hexanes/ ethyl acetate) to provide 
aldehyde 104 (1.84 g, 10.7 mmol, 61%) as a colorless oil. Spectral data was consistent 
with reported values. 25 
 
To a solution of aldehyde 104 (1.0 eq, 900 mg, 5.2 mmol) in 
CH2Cl2 (50 mL) at ambient temperature was added 
formylmethylene triphenylphosphorane (1.0 eq, 1.6 g, 5.2 mmol). After warming to 
reflux, the reaction was stirred 3 h. Celite (1 g) was added and the reaction was 
concentrated in vacuo. The crude residue was purified by column chromatography (4:1 
hexanes/ ethyl acetate) to provide aldehyde 106 (680 mg, 3.4 mmol, 66%) as a pale 
yellow oil. 1H NMR (400 MHz CDCl3): δ 9.7 (d, J = 7.6 Hz, 1H), 6.75 (dd, J = 15.6, 4.8 
Hz, 1 H), 6.21 (dd, J = 15.6, 7.6 Hz, 1H), 5.52 (dd, J = 6.8, 5.2, 1H), 2.13 (s, 3H), 1.75-
1.69 (m, 2H), 1.44-1.27 (m, 6H), 0.93-0.89 (m, 3H); 13C (100 MHz, CDCl3) δ 192.9, 
170.0, 153.9, 131.4, 33.5, 31.3, 24.6, 22.3, 20.9, 13.9. 
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To a solution of aldehyde 106 (1.0 eq, 198 mg, 1 mmol) in 
EtOH (10 mL) at ambient temperature was added sodium 
borohydride (1,0 eq, 380 mg, 10 mmol) and the reaction was stirred 1 h. The reaction 
mixture was concentrated in vacuo and the crude residue dissolved in ethyl acetate (10 
mL). The organics were washed with water (1 x 10 mL), brine (1 x 10 mL), dried 
(MgSO4), filtered and concentrated in vacuo. The crude alcohol was lowered to – 20 °C. 
Ethyl vinyl ether (10 eq, 740 mg, 10 mmol) was added and the reaction was allowed to 
stir 5 minutes. N-bromosuccinimide (1.0 eq, 178 mg, 1 mmol) was added while 
maintaining an internal temperature below 0 C. After 30 min, hexanes (10 mmol) was 
added and the reaction filtered through a plug of celite. The organics were washed with 
1N HCl (3 x 10 mL), dried (MgSO4), filtered, and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (6:1 hexanes/ ethyl acetate) to 
provide acetal 108 (284 mg, 0.81 mmol, 81%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 5.83-5.68 (m, 2H), 5.27 (dd, J = 6.8, 6.4 Hz, 1 H), 4.71 (t, J = 5.6 Hz, 1H), 
4.19-4.07 (m, 2H), 3.74-3.56 (m, 2H), 3.38 (d, J = 5.6 Hz, 1H), 2.06 (s, 3H), 1.66-1.54 
(m, 2H), 1.30-1.21 (m, 6H), 0.91-0.88 (m, 3H); 13C (100 MHz, CDCl3) δ 170.3, 131.4, 
128.3, 100.9, 73.9, 66.3, 62.4, 34.2, 31.6, 31.4, 24.7, 22.4, 21.2, 15.1, 13.9. 
 
To a solution of bromoacetal 108 (1.0 eq, 40 mg, 0.11 mmol) in 
benzene (5 mL) was added tributyl tin hydride (1.1 eq, 30 µL, 0.12 
mmol). The solution was degassed and then AIBN (1 crystal) was added. Heated to reflux 
(80 °C). After 3 hours, concentrated in vacuo. The residue was dissolved in Et2O (5 ml), 
washed 2 x 5 mL 10% KF, dried (MgSO4), filtered through Celite, and concentrated in 
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vacuo. The crude residue was purified by column chromatography (8:1 hexanes/ ethyl 
acetate) to provide lactol 109 (23 mg, 0.08 mmol, 75%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 5.29 (s, 1H), 5.12-5.08 (m, 1H), 4.91-4.83 (m, 1H), 3.78 (dt, J = 24, 8 
Hz, 1H), 3.72 (ddd, J = 8, 7, 1 Hz, 1H), 3.47 (m, 2H), 2.35-2.15 (m, 2H), 2.04 (s, 3H), 
1.73-1.60 (m, 2H), 1.49-1.43 (m, 4H), 1.30-1.19 (m, 6H), 0,9-0.86 (m, 3H)  13C (100 
MHz, CDCl3) δ 170.7, 104.1, 73.4, 73.2, 71.6, 71.5, 39.3, 39.1, 37.3, 37.2, 35.4, 31.2, 
24.8, 22.4, 15.1, 13.9. 
 
To a solution of lactol 109 (1.0 eq, 80 mg, 0.30 mmol) in acetone (3 
mL) added 1 mL of a solution of Jones reagent (1:9 Jones reagent: 
acetone). The reaction was monitored by TLC. After 30 minutes, the reaction was 
quenched with ethanol (1 mL). The reaction was diluted with ether (5 mL) and washed 
with H2O (1 x 5 mL), sodium bicarbonate (1 x 5 mL), and brine (1 x 5 mL). The organics 
were dried (MgSO4) and filtered. The crude residue was purified by column 
chromatography (4:1 hexanes/ ethyl acetate) to provide lactone 110 (50 mg, 0.20 mmol, 
71%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ  4.90 (m, 1H), 4,42 (m, 1H), 3.93 
(dd, J = 16, 8 Hz, 1H), 2.70-2.55 (m, 2H), 2.21 (dd, J = 16,  8 Hz, 2H), 2.06 (s, 3H), 1.73 
(m, 2H), 1.58-1.53 (m, 3H), 1.27 (m, 6H), 0.90-0.87 (m, 3H)  13C (100 MHz, CDCl3) δ 
176.7, 170.7, 73.2, 72.9, 72.4, 72.1, 37.4, 32.8, 31.5, 24.8, 22.4, 21.1, 13.9. 
 
 To a freshly prepared solution of LDA (1.0 eq, 0.10 mmol) in THF (1 
mL) was added lactone 110 (1.0 eq, 25 mg, 0.10 mmol) at 0 °C. 
Stirred at 0 °C for 1 hour, then cooled to -78 °C and added HMPA (20 µL) and methyl 
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cyanoformate (1.0 eq, 10 µL, 0.10 mmol). Stirred 30 min at -78 °C then poured reaction 
into cold water (1 mL). Extracted (3 x 5 mL) Et2O, dried (MgSO4), and concentrated with 
Celite. The crude residue was purified by column chromatography (4:1 hexanes/ ethyl 
acetate) to provide ester 111 (18 mg, 0.07 mmol, 70%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 4.69 (m, 1H), 4.46 (t, J = 8 Hz, 1H), 3.94 (t, J = 8 Hz, 1 H), 3.78 (s, 3H), 
3.47 (d, J = 8 Hz, IH), 3.15 (dd, J = 16, 8 Hz, 1H), 2.43 (s, 3H), 1.78 – 1.74 (m, 2H), 
1.35-1.20 (m, 6H), 0.90-0.88 (m, 3H). 
 
To a solution of acetonide 99 (1.0 eq, 5 mg, 10 µmol) in CDCl3 (600 
µL) in an NMR tube was added 1 drop of trifluoroacetic acid. 
Reaction progress was monitored by NMR. After 1 hour, the reaction 
was concentrated in vacuo and the crude residue was purified by column chromatography 
(1:1 hexanes/ ethyl acetate) to provide diol 100 (2 mg, 4.0 µmol, 50%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ 7.37-7.31 (m, 5H), 6.95 (d, J = 1.5 Hz, 1H), 5.69 (d, J = 4, 
1 Hz, 1H), 5.33 (td, J = 11.4, 4 Hz, 1H), 4.37 (dd, J = 18, 11.2 Hz, 2H), 4.14 (dd, J = 14, 
6.7 Hz, 1H), 3.95 (m, 1H), 3.68-3.63 (m, 2H), 3.55 (dd, J = 7.8, 1.5 Hz, 1H), 3.35 (t, J = 
8 Hz, 1H), 3.15 (t, J = 6 Hz, 1H), 2.90 (ddd, J = 10, 8, 1.8 Hz, 1H), 2.15 (s, 3H), 2.05 (d, 
J = 1.8 Hz, 1H), 1.95 (s, 3H), 1.34 (s, 3H). 
 
To a solution of diol 100 (1.0 eq, 3 mg, 6.0 µmol) in ethyl acetate (500 
µL) at ambient temperature was added lead tetraacetate (3 mg). After 30 
min, filtered reaction through a plug of celite and obtained aldehyde  84 
(2 mg, 4 µmol, 75%) as a pure white solid. 1H NMR (400 MHz, CDCl3) δ 9.43 (s, 1H), 
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7.38-7.31 (m, 5H), 7.02 (d, J = 1.4 Hz, 1H), 5.76 (s, 1H), 5.35 m, 1H), 4.37 (dd, J = 19, 
11.4 Hz, 2H), 4.14 (dd, J = 14, 7 Hz, 1H), 3.59-3.51 (m, 2H), 2.90 (ddd, J = 10, 8, 2 Hz, 
1H), 2.23 (s, 3H), 2.07 (s, 3H), 2.03 (s, 3H).  
 
To a solution of aldehyde 84 (1.0 eq, 3 mg, 7.0 µmol) in CH2Cl2 (1 
mL) was added formylmethylene triphenylphosphorane (1.0 eq, 2 mg, 
7.0 µmol). The reaction was heated to reflux (40 °C). After 2 hours, 
concentrated reaction with Celite and purified residue by column chromatography (1:1 
hexanes/ ethyl acetate) to provide aldehyde 113 (2 mg, 4.0 µmol, 61%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ 9.53 (d, J = 7.6 Hz, 1H), 7.38-7.31 (m, 5H), 7.02 (d, J = 
1.4 Hz, 1H), 6.73 (dd, J = 15, 6 Hz, 1H), 6.29 (dd J = 15.7, 6.7 Hz, 1H), 6.1 (d, J = 5.1 
Hz, 1H), 5.29-5.25 (m, 1H), 4.35 (dd, J = 20, 11.3 Hz, 1H), 2.87 (dd, J = 16, 8 Hz, 1H), 
2.16 (s, 3H), 1.91 (s, 3H), 1.5 (s, 3H).    
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Appendix A: 
 
Spectra of Relevant Compounds  
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Figure A1 1H NMR spectra (400 MHz, CDCl3) of compound 103 
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Figure A2 13C NMR spectra (100 MHz, CDCl3) of compound 103 
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Figure A3 1H NMR spectra (400 MHz, CDCl3) of compound 106 
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Figure A4 13C NMR spectra (100 MHz, CDCl3) of compound 106 
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Figure A5 1H NMR spectra (400 MHz, CDCl3) of compound 108 
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Figure A6 13C NMR spectra (100 MHz, CDCl3) of compound 108 
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Figure A7 1H NMR spectra (400 MHz, CDCl3) of compound 109 
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Figure A8 13C NMR spectra (100 MHz, CDCl3) of compound 109 
OA
c 1
09
4
O
OE
t
35	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A9 1H NMR spectra (400 MHz, CDCl3) of compound 110 
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Figure A10 13C NMR spectra (100 MHz, CDCl3) of compound 110 
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Figure A11 1H NMR spectra (400 MHz, CDCl3) of compound 111 
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Figure A12 1H NMR spectra (400 MHz, CDCl3) of compound 100	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Figure A13 1H NMR spectra (400 MHz, CDCl3) of compound 84	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Figure A14 1H NMR spectra (400 MHz, CDCl3) of compound 113 
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